ATS
The American Thoracic Society improves global health by advancing research, patient care, and public health in pulmonary disease, critical illness, and sleep disorders.
Conference Highlights
Expert Interviews
Featured
Racial Disparities Persist in Respiratory Disease Research, Diagnostics: Expert Panel Discussion at 2024 ATS
Giuliana Grossi
May 28 2024
Tezepelumab Reduces Rate of COPD Exacerbations in Individuals with Wide Range of Blood Eosinophil Levels: Phase 2a COURSE Trial Findings
Grace Halsey
May 20 2024
AstraZeneca at ATS 2024: Look for Late-Breaking Data on Novel Therapeutics for COPD
Grace Halsey
May 8 2024
NAVIGATOR: Tezepelumab Reduces Asthma Exacerbations by More than Half
Sydney Jennings
May 20 2022
Review of Biologic Treatments for Asthma Finds Inconsistent Effects on Airway Hyperresponsiveness
Sydney Jennings
May 19 2022
Tezepelumab Reduces Asthma Exacerbations by More than Half, Reports NAVIGATOR Study Author
Sydney Jennings
May 19 2022
Real-world Data Showed Mepolizumab Reduced Exacerbations, Oral Corticosteroid Use in Adults with Severe Asthma
Sydney Jennings
May 18 2022
Novel PDE4B Inhibitor Slows Lung Function Decline in IPF: Phase 2 Data from Boehringer Ingelheim
Grace Halsey
May 17 2022
NAVIGATOR Data Presented at ATS 2022 Show Improved Clinical Responses to Treatment with Tezepelumab vs Placebo
Sydney Jennings
May 16 2022
Novel Fixed-dose Albuterol-Budesonide Inhaler Significantly Reduced Exacerbation Risk in Severe Asthma
Grace Halsey
May 16 2022
Objective Confirmation of Asthma Diagnosis Often Missing in Primary Care, Study Suggests
Grace Halsey
May 14 2022
ATS 2021: Tezepelumab Reduces Exacerbations in Oral Corticosteroid-dependent Patients with Severe Asthma
Sydney Jennings
May 13 2021
ATS.2021: Study Finds Odds of Uncontrolled Asthma Increase with Higher Pandemic-related Stress
Grace Halsey
May 13 2021
ATS.2021: At-risk Asthma Phenotypes Defined Using 4 Simple Metrics
Grace Halsey
May 12 2021
ATS 2021: Severe COPD Exacerbations May be Associated with Increased Mortality Risk
Sydney Jennings
May 12 2021
ATS 2021: Researchers Project Burden of COPD Will be Worse in 2050, Especially in US
Sydney Jennings
May 11 2021
ATS 2021: Triple Combination Therapy May Benefit “Wide Spectrum” of Patients with COPD
Sydney Jennings
May 11 2021
Can Telehealth Bridge Disparities in Access to Pulmonary Rehab?
Christina Bennett, MS
May 24 2019
From ATS 2019: Update on Factors that May Help Predict ILD Outcomes
Christina Bennett, MS
May 23 2019
ATS Highlights Advances in the Prediction of COPD Outcomes
Christina Bennett, MS
May 23 2019
E-Cigarettes: The New Addiction and Why Physicians Must be Concerned
Christina Bennett, MS
May 22 2019
Rethinking Supplemental Oxygen: Physicians, Patients, and Caregivers Weigh In
Christina Bennett, MS
May 21 2019
A Pro-Con Debate on How to Care for Patients With Interstitial Lung Disease
Christina Bennett, MS
May 21 2019
A Non-smoker with Progressive Dyspnea, No Cough
Jonathan Ilowite, MD
January 1 2018
COPD Exacerbations: Frequently Asked Questions
Jonathan Ilowite, MD
January 1 2018
A Primary Care Approach to Interstitial Lung Disease
Jonathan Ilowite, MD
November 27 2017
A Case of Worsening Dyspnea and Cough
Jonathan Ilowite, MD
November 26 2017
